Visual Performance Following Implantation of Presbyopia Correcting IOLs
NCT ID: NCT04907955
Last Updated: 2021-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2019-06-01
2020-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of FineVision Intraocular Lenses vs Symfony Intraocular Lenses
NCT03974451
Visual Outcomes After Presbyopic Lens Exchange
NCT03790592
Visual Performance of Four Types of Multifocal Intraocular Lenses
NCT03454334
Photopic and Mesopic Multifocal IOL Performance
NCT06978556
Clinical Study to Evaluate the Visual Performance of Three Multifocal IOLs
NCT02990689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
panoptix PANFOCAL intraocular lens
panoptix PANFOCAL intraocular lensis a single-piece aspheric non-apodized diffractive panfocal IOL that distributes light energy to three focal points in both small and large pupil conditions
phacoemulsification with implantation of presbyopia correcting IOL
cataract extraction with phacoemulsification and insertion of presbyopia correcting IOL
Trifocal Diffractive the AT LISA intraocular lens
Trifocal Diffractive the AT LISA is a preloaded single-piece aspheric diffractive trifocal IOL and made of hydrophilic acrylic with a hydrophobic surface with an ultraviolet absorber. This aspheric IOL is aberration -correcting in order to reduce and compensate for corneal spherical aberrations.
phacoemulsification with implantation of presbyopia correcting IOL
cataract extraction with phacoemulsification and insertion of presbyopia correcting IOL
Symphony EDOF (extended depth of focus) intraocular lens
SYMPHONY EDOF intraocular lens is a single-piece aspheric biconvex hydrophobic acrylic IOL with a 6.0 mm optic and an 13.0 mm overall diameter. This IOL consists of a wavefront-designed anterior aspheric surface (negative spherical aberration of -0.27 mm to counterbalance the net positive spherical aberration from cornea) and a posterior achromatic diffractive surface with echelette design.
phacoemulsification with implantation of presbyopia correcting IOL
cataract extraction with phacoemulsification and insertion of presbyopia correcting IOL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
phacoemulsification with implantation of presbyopia correcting IOL
cataract extraction with phacoemulsification and insertion of presbyopia correcting IOL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* ocular pathology or corneal abnormalities.
* an endothelial cell count below 2000 cells/mm2.
* corneal astigmatism greater than 1.0 diopter (D) measured with Scheimpflug tomography (Sirius, CSO, Italy).
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dar Al Shifa Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
magda torky
Principle investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Daralshifa hospital
Kuwait City, , Kuwait
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02282021065727
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.